See All Slides - tctmd.com

Slides

Presentation Cell Therapy 2014

INTRACORONARY INFUSION OF BONE MARROW-DERIVED SELECTED CD34+CXCR4+ CELLS AND NON-SELECTED MONONUCLEAR CELLS IN PATIENTS WITH ACUTE STEMI AND REDUCED LVEF

Presenter: Micha? Tendera

January 22, 2014

Presentation Cell Therapy 2014

Ventrix Solutions for the Heart

Presenter: Paul Chamberlin

January 21, 2014

Presentation Cell Therapy 2014

Mobilization of Stem and Progenior Cells Just a Marker or Reparatory Mechanism

Presenter: Wojciech Wojakowski

January 21, 2014

Presentation ISET 2014

Long Segment Tibial Occlusions: Which Technologies Work Best?

Presenter: Marco Manzi

January 21, 2014

Presentation ISET 2014

How Important Are Re-entry Devices and How to Use Them

Presenter: James F. Benenati

January 21, 2014

Presentation

Bioresorbable Vascular Scaffolds in Acute STEMI

Presenter: V. Ko?ka

January 21, 2014

Presentation Cell Therapy 2014

Erythropoietin and AMI Regeneration - New Issues from Local Drug Release

Presenter: Christian Klopsch

January 21, 2014

Presentation Cell Therapy 2014

The promise of biomaterial delivery vehicles for improving stem cell retention in the infarcted heart

Presenter: Ellen Roche

January 21, 2014

Presentation Cell Therapy 2014

New Insights into Paracrine Activity of Stem Cells in Heart Repair - Microvesicles and Proteomics

Presenter: Ewa K. Zuba-Surma

January 21, 2014

Presentation ISET 2014

Thrombus Laden Occlusions: Covered Stents vs. Lysis

Presenter: Richard R. Saxon

January 21, 2014

Advertisement

Slides

INTRACORONARY INFUSION OF BONE MARROW-DERIVED SELECTED CD34+CXCR4+ CELLS AND NON-SELECTED MONONUCLEAR CELLS IN PATIENTS WITH ACUTE STEMI AND REDUCED LVEF

Ventrix Solutions for the Heart

Mobilization of Stem and Progenior Cells Just a Marker or Reparatory Mechanism

Long Segment Tibial Occlusions: Which Technologies Work Best?

How Important Are Re-entry Devices and How to Use Them

Bioresorbable Vascular Scaffolds in Acute STEMI

Erythropoietin and AMI Regeneration - New Issues from Local Drug Release

The promise of biomaterial delivery vehicles for improving stem cell retention in the infarcted heart

New Insights into Paracrine Activity of Stem Cells in Heart Repair - Microvesicles and Proteomics

Thrombus Laden Occlusions: Covered Stents vs. Lysis

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content